Investment
Features
FeesSafety
Academy
More
Pluang+

Compare RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) vs Health Care Select Sector SPDR Fund — how do they compare? RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B), while Health Care Select Sector SPDR Fund trades at $176.17 (market cap $43.92B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is the larger of the two by market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.47% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.

RELXXLV
Market Cap
$63.89B$43.92B
Volume
2,760,50211,816,834
Sector
Industrials—
52-Week High
$46.80$175.68
52-Week Low
$27.73$142.33
Enterprise Value
$75.40B—
Dividend Yield
2.47%—
Typical Hold Time
—100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Health Care Select Sector SPDR Fund

XLV trades at $169.66, down 1.35% today, while maintaining a bullish technical outlook with strong moving average signals. The healthcare ETF's low 0.08% expense ratio and diversified exposure to 61 S&P 500 healthcare stocks provide cost-effective sector access. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.

Outlook remains positive given healthcare's defensive positioning amid economic uncertainty, though overbought RSI levels suggest near-term consolidation. Key risks include sector-specific regulatory pressures and election-related policy uncertainty that could impact healthcare stocks through 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RELX

No sentiment data available yet.

XLV
55% Buy45% Sell
Avg holding period · 100 Days

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →